| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787869 | Journal of Thoracic Oncology | 2018 | 6 Pages |
Abstract
The ORR for SCAI was significantly higher than that for LCBI. These data indicate that anti-PD-1/PD-L1 inhibitors could make tumors more vulnerable to subsequent chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Song Ee MD, Se Hoon MD, PhD, Jin Seok MD, PhD, Myung-Ju MD, PhD, Keunchil MD, PhD, Jong-Mu MD, PhD,